EPCAM and colorectal cancer: Liu et al. conjugated α-amanitin to an anti-epithelial cell adhesion molecule (EpCAM) antibody and demonstrated complete tumor regression in mouse models of human colorectal cancer with a hemizygous loss of POLR2A18.